Despite the notable achievements of the technology, Leonard Lichtenfeld, the American Cancer Society’s Deputy Chief Medical Officer warns that MasSpec still has a ways to go before reaching perfection:
What is Next for the MasSpec Pen?
Thus far, no one has tested the results of the technology on a person undergoing surgery. Ensuring that no undesirable consequences follow from these tests is important as well. However, the MasSpec Pen will be placed in three hospitals in the state of Texas.
The technology will also require approval from the Food and Drug Administration (FDA). Additional tests and potential alterations may need to follow prior to the assent of the MasSpec Pen.
Fox News moreover states that multiple years may pass before the completion of the FDA’s process of regulations.